These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 34064049)

  • 21. A Prospective Cohort Study of Novel Markers of Hepatitis B Virus Replication in Human Immunodeficiency Virus Coinfection.
    Chung RT; King WC; Ghany MG; Lisker-Melman M; Hinerman AS; Khalili M; Sulkowski M; Jain MK; Choi EK; Nalesnik MA; Bhan AK; Cloherty G; Wong DK; Sterling RK;
    Clin Gastroenterol Hepatol; 2023 Jan; 21(1):125-135.e8. PubMed ID: 34973459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining Hepatitis B Virus RNA and Hepatitis B Core-Related Antigen: Guidance for Safely Stopping Nucleos(t)ide Analogues in Hepatitis B e Antigen-Positive Patients With Chronic Hepatitis B.
    Fan R; Peng J; Xie Q; Tan D; Xu M; Niu J; Wang H; Ren H; Chen X; Wang M; Sheng J; Tang H; Bai X; Wu Y; Zhou B; Sun J; Hou J;
    J Infect Dis; 2020 Jul; 222(4):611-618. PubMed ID: 32211776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of HBV serological markers in treatment-naïve HBV mono-infected patients and HBV-HIV co-infected patients.
    Jiang B; Su R; Ren D; Zheng X; Cao Y; Mi Y; Wang F; Ma P
    Virus Res; 2020 Dec; 290():198117. PubMed ID: 32800804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy.
    Inoue T; Watanabe T; Tanaka Y
    Clin Mol Hepatol; 2023 Oct; 29(4):851-868. PubMed ID: 36891607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum hepatitis B core-related antigen as a treatment predictor of pegylated interferon in patients with HBeAg-positive chronic hepatitis B.
    Chuaypen N; Posuwan N; Payungporn S; Tanaka Y; Shinkai N; Poovorawan Y; Tangkijvanich P
    Liver Int; 2016 Jun; 36(6):827-36. PubMed ID: 26678018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum HBV RNA correlated with intrahepatic cccDNA more strongly than other HBV markers during peg-interferon treatment.
    Wang X; Chi X; Wu R; Xu H; Gao X; Yu L; Liu L; Zhang M; Tan Y; Niu J; Jin Q
    Virol J; 2021 Jan; 18(1):4. PubMed ID: 33407619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Hepatitis B Core-Related Antigen With Hepatitis B Virus Reactivation in Occult Viral Carriers Undergoing High-Risk Immunosuppressive Therapy.
    Seto WK; Wong DK; Chan TS; Hwang YY; Fung J; Liu KS; Gill H; Lam YF; Cheung KS; Lie AK; Lai CL; Kwong YL; Yuen MF
    Am J Gastroenterol; 2016 Dec; 111(12):1788-1795. PubMed ID: 27644733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B.
    Seto WK; Wong DK; Fung J; Huang FY; Liu KS; Lai CL; Yuen MF
    Clin Microbiol Infect; 2014 Nov; 20(11):1173-80. PubMed ID: 24975365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B.
    Chang XJ; Sun C; Chen Y; Li XD; Yu ZJ; Dong Z; Bai WL; Wang XD; Li ZQ; Chen D; Du WJ; Liao H; Jiang QY; Sun LJ; Li YY; Zhang CH; Xu DP; Chen YP; Li Q; Yang YP
    World J Gastroenterol; 2019 Aug; 25(32):4764-4778. PubMed ID: 31528100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of circulating HBV RNA expressed from intrahepatic cccDNA in untreated and NUC treated patients with chronic hepatitis B.
    Testoni B; Scholtès C; Plissonnier ML; Paturel A; Berby F; Facchetti F; Villeret F; Degasperi E; Scott B; Hamilton A; Heil M; Lampertico P; Levrero M; Zoulim F
    Gut; 2024 Mar; 73(4):659-667. PubMed ID: 37879886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B.
    Loggi E; Vukotic R; Conti F; Grandini E; Gitto S; Cursaro C; Galli S; Furlini G; Re MC; Andreone P
    J Viral Hepat; 2019 May; 26(5):568-575. PubMed ID: 30576048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The significance of detecting HBV pgRNA and HBcrAg in HBV patients treated with NAs.
    Lin J; Jiang S; Chen X; Zhu M; Zhang H
    Medicine (Baltimore); 2024 Apr; 103(14):e37752. PubMed ID: 38579047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A longitudinal study to detect hepatitis B surface and core-related antigens in chronic hepatitis B patients with hepatitis B surface antigen seroclearance using highly sensitive assays.
    Wong DK; Inoue T; Mak LY; Hui RW; Fung J; Cheung KS; Seto WK; Tanaka Y; Yuen MF
    J Clin Virol; 2023 Mar; 160():105375. PubMed ID: 36623378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum HBsAg quantification in treatment-naïve Indian patients with chronic hepatitis B.
    Ramachandran J; Ismail AM; Chawla G; Fletcher GJ; Goel A; Eapen CE; Abraham P
    Indian J Gastroenterol; 2014 Mar; 33(2):131-5. PubMed ID: 24052375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New perspectives of biomarkers for the management of chronic hepatitis B.
    Lin CL; Kao JH
    Clin Mol Hepatol; 2016 Dec; 22(4):423-431. PubMed ID: 28081591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B.
    Mak LY; Wong D; Kuchta A; Hilfiker M; Hamilton A; Chow N; Mao X; Seto WK; Yuen MF
    Clin Mol Hepatol; 2023 Jan; 29(1):146-162. PubMed ID: 35989092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B virus core-related antigen (HBcrAg) as a prognostic marker for the development of hepatocellular carcinoma: A mini systematic review of the literature.
    Afifi AM; Elgenidy A; Hashim M; Awad AK; Jalal PK
    Rev Med Virol; 2022 Nov; 32(6):e2353. PubMed ID: 35441759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma.
    Wu JW; Kao JH; Tseng TC
    Clin Mol Hepatol; 2021 Oct; 27(4):524-534. PubMed ID: 33618507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Predictive Value of Baseline Serum Marker Levels for the Effect of Interferon Therapy in Patients With Chronic Hepatitis B].
    Yan Y; Davgadorj C; Lyu C; Lu Z; Yu P
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):383-390. PubMed ID: 38645851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive role of early treatment dynamics of HBV RNA and HBcrAg for HBeAg seroconversion in children with chronic hepatitis B.
    Lai X; OuYang W; Li S; Qiu J; Zhang H; Jiang T; Qin X; Tang L; Gu Y; Yao Z; Peng S
    J Med Virol; 2024 May; 96(5):e29670. PubMed ID: 38773810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.